AEF0217 in Participants With Down Syndrome

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

France

CHU de Bordeaux, Bordeaux

Genetics department, Hospices Civils de Lyon, Lyon

Service Génétique Médicale, CHU de Montpellier, Montpellier

Genetics department, Institut Jérôme Lejeune, Paris

Service de Génétique, Chromosomique et Moléculaire, Chu de Saint Etienne, Saint-Etienne

Italy

IRCCS Istituto Delle Scienze Neurologiche, Azienda Unita Sanitaria Locale Di Bologna, Bologna

Centro di Medicina dell'Invecchiamento, Policlinico Universitario Agostino Gemelli IRCCS, Roma

UOR of Neurofarmacology and Translational Neurosciences, Associazione Oasi Maria S.S.Onlus, Troina

Spain

Integrative Pharmacology and Systems Neurosciences, Hospital del Mar Research Institute, Barcelona

Servicio de Medicina Interna, Hospital Universitario De La Princesa, Madrid